BUSINESS/FINANCE NEWS
Setup News Ticker
   BUSINESS/FINANCE NEWS
Searching for 'Stimulus Market'. (Return)

Yahoo BusinessOct 30, 2020
Nasdaq Hits Correction Mode, Dow Touches 200-Day Moving Average In Volatile Friday Trade
If there were any doubts left about whether the market would be "risk-on" or "risk-off" going into the election, Friday's selloff pretty much iced it. The toggle has switched to the off position.The late-week meltdown ignited after earnings from four of the five FAANGs that were mostly positive, but perhaps lacking in the guidance department (see more below). Combine that with the resurgence of COVID-19, the Senate adjourning with no more progress on a stimulus package, and the culmination of a long and contentious election season, and it's no wonder investors seem ready for a break. Even before FAANG earnings officially put things on ice, many investors showed signs of risk aversion ahead of the election. That made itself pretty clear with selloffs on Monday and Wednesday. Major indices suffered their worst week since March, and now people are openly making comparisons between this pre-election skid and the one we saw heading into the 2016 election.As noted this morning, keep an eye on futures Sunday night into Monday, and especially on Tuesday night as returns come in. Election night 2016 was a wild one for the futures market, featuring a steep plunge when it initially looked like results might be contested, followed by a meteoric rally when it became clear there'd be a victor without much fuss or muss.A wild ride could play out this time if things look testy by late Tuesday night. Or, if it looks relatively smooth, stocks could get a lift. It's arguably not so

KiplingerOct 30, 2020
Stock Market Today: Big Tech Beatdown Keeps Stocks in a Slump
The usual store of worries -- election uncertainty, COVID's resurgence and stalled stimulus -- no doubt weighed large on investors during a broadly brutal Friday for U.S. equities.

But Big Tech gets a special nod for its role in dragging down the wider market.

SEE MORE 15 Dividend-Paying Stocks to Sell or Avoid Apple (AAPL) slightly topped earnings expectations, but shares slumped 5.6% amid a 20% decline in quarterly sales and a lack of forward-looking guidance.

It wasn't all bad. "The bang-bang launches of iPad Air, Watch series 6, the service bundles, and the new 5G iPhones in autumn show that Apple is firing on all cylinders," writes Argus Research's Jim Kelleher (Buy, $150 price target), who adds that "the September iPad and Watch launch and the October iPhone launch should drive momentum for Apple products heading into the holiday season."

Facebook's (FB) top and bottom lines easily exceeded estimates, but declining volume of U.S. and Canadian users triggered a 6.3% exodus from shares. And Amazon.com (AMZN)? A Street-beating 37% jump in revenues, and profits that were 67% better than estimates … but the stock sank 5.5% thanks to disappointing Q4 earnings estimates amid high COVID-related costs.

"None of Thursday's tech earnings results were bad, and some were spectacular," says David Bahnsen, chief investment officer of wealth management firm The Bahnsen Group, "but the mar


Yahoo BusinessOct 30, 2020
3 Biotech Stocks in the Hunt for COVID-19 Vaccine; One Analyst Calls Them a ‘Buy'
Nearly a year into a global pandemic the world is still on the back of its heels. In the face of ever increasing infection rates, world economies have slowed rapidly and unemployment has increased significantly, and now governments are reconsidering shutting down entire countries once again. At the same time, the federal government has failed to pass a second stimulus package to prop up individuals who have lost their jobs and may be facing homelessness, as well as the need to help state and local governments provide a backstop against their own losses.Given this backdrop, there is a lot riding on a potential vaccine and/or cure for COVID-19. There are many approaches that a lengthy list of varying companies are taking to bring their respective product to market.Any company that does successfully bring a product to market that helps in the fight against the virus may see a significant increase in revenues as well as an in-kind increase in profits. B. Riley Securities has highlighted three biotech companies that are approaching the virus from different directions. We ran the trio through TipRanks' database to see how B. Riley's recent analysis compared to other analysts' projections.Altimmune Inc. (ALT)Altimmune is a biopharmaceutical company that develops vaccines and immune modulating therapies. Fighting the virus is likely to need both approaches, a vaccine as well as an immune therapy. With this kind of focus, Altimmune's fortunes changed quickly with the onset of the COV
TRENDING TAGS
ElectionStocks Biden Since Dow Points
Stockmarket Apple Election Tech Earnings
EarningsCall Transcript Q3 Inc Corp
StocksTech Cruise CDC Election Since
COVID-19cases trial Regeneron patients Europe
Sinceworst March Week Dow Global
CallEarnings Transcript Q3 Inc Corp
Coronaviruscases rise latest counts record
Marchworst since Week Dow Global
TranscriptEarnings Call Q3 Inc Corp

NEWS SOURCES
Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Entrepreneur.com
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
Inc.com
INSEAD Knowledge
International Tax Review
Kiplinger
Knowledge@Wharton
L.S. Starrett News
MarketWatch
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
OpinionJournal.com
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
SHRM HR News
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ US News
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • 617 482 1200
    617 299 8649 (fax)
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2020 CEOExpress Company LLC